Powering the answers to the toughest questions in cancer

M2Gen connects patients, providers, and researchers to fundamentally change the way cancer is studied and treated

Learn More

Purpose-driven and Patient-centric

Next Generation

Impacting Healthcare for the Next Generation

M2Gen is an oncology-focused health informatics solutions company with the mission to help patients get access to the best treatments by leveraging clinical and molecular data to accelerate the discovery, development, and delivery of tailored and more personalized therapies. M2Gen's approach is to transform cancer care through genomic analysis of patient-derived tumor specimens, and translating new molecular observations combined with clinical insights into individual therapeutics and diagnostic tools. 

Learn More

Next Generation

Accelerating Precision Medicine

M2Gen partners with 19 of the nation’s leading cancer centers, through the Oncology Research Information Exchange Network® (ORIEN), to deliver oncology informatics-based solutions to accelerate therapy discovery, development and delivery of precision medicine

Understand how M2Gen is transforming cancer research through collaboration and partnership

See More

Patient Transparency & Partnership

M2Gen is one of the only companies to ensure that patient data has been granted through consent

M2Gen utilizes the IRB-approved protocol, Total Cancer Care®, that allows for enhanced patient engagement through the ability to re-contact patients and facilitates linkages across disparate sources of data, creating a research ecosystem which can significantly benefit patients and improve patient care.

See how M2Gen is aggregating and analyzing healthcare data for actionable insights

See More

Globally Recognized Expertise

Scientific Leadership

M2Gen, Total Cancer Care, ORIEN and its leaders have been globally recognized for groundbreaking work in advancing precision medicine

Learn More

Our Latest Developments

  1. M2Gen® Appoints Dr. Helge Bastian President and Chief Executive Officer

  2. M2Gen® Donates $3M for Inaugural ORIEN NOVA Grants to Support Cancer Research Projects

  3. PMWC Silicon Valley: Interview with Judy Barkal

If you like how M2Gen is fundamentally advancing how cancer is studied and treated, join us!

See More